Recalls from Carter BloodCare
Carter BloodCare Red Blood Cells, Leukocytes Reduced
(opens in a new tab)
Low risk
,
FDA
,
Sep 22, 2026
,
Processing problem
Carter BloodCare Red Blood Cells, Leukocytes Reduced
(opens in a new tab)
Moderate risk
,
FDA
,
Jul 2, 2026
,
Blood donor screening
Data: Recall Canary
(opens in a new tab)